sp-3164
salarius pharma
['sp-3164', 'salarius']
attending the 64th annual meeting and expo? be sure to join daniela santiesteban, phd, as she presents preclinical findings on the significant anti-cancer activity of novel protein degrader sp-3164. abstract: 
Salarius is a cancer-focused biotechnology company. Currently in clinical trials for Ewing Sarcoma w/ Orphan Drug & Rare Pediatric Disease Designation.